No profile data available.
Deltagen Inc. (DGEN) is a healthcare company in the targeted healthcare equipment industry, based in San Mateo, United States.
It reported revenue of $9.78 million for fiscal year 2006, up 45.9% from fiscal year 2005, and net income of $4.37 million. In Q2 2007 (the quarter ended June 30, 2007) revenue was $617,000, down 83.5% from a year before. Its market capitalization was $2.75 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2006; market data as of October 8, 2026.
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets.
Deltagen reported $9.78 million in revenue for fiscal year 2006, up 45.9% from $6.70 million in fiscal year 2005. In Q2 2007 revenue was $617,000.
$2.75 million as of October 8, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Global Tech Industries Group, Inc. (GTII), Nexalin Technology, Inc. (NXL), Vasamed, Inc. (VSMD), REMSleep Holdings, Inc. (RMSL).